Vaccine responses to conserved regions of the HIV-1 proteome are associated with an increased capacity to inhibit multiple virus isolates ex vivo

Samankaltaisia teoksia

• Broad HIV Epitope Specificity and Viral Inhibition Induced by Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults
  Tekijä: Kopycinski, Jakub, et al.
  Julkaistu: (2014)
• A DNA-Based Candidate HIV Vaccine Delivered via In Vivo Electroporation Induces CD4 Responses toward the α4β7-Binding V2 Loop of HIV gp120 in Healthy Volunteers
  Tekijä: Kopycinski, Jakub, et al.
  Julkaistu: (2012)
• P14-01. Care and treatment for volunteers in IAVI-sponsored HIV vaccine clinical trials in India
  Tekijä: Kochhar, S, et al.
  Julkaistu: (2009)
• A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults.
  Tekijä: Michael C Keefer, et al.
  Julkaistu: (2012-01-01)
• A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults
  Tekijä: Keefer, Michael C., et al.
  Julkaistu: (2012)